The leader of the U.S. Food & Drug Administration’s CBD Working Group is leaving the agency, FDA Acting Director Janet Woodcock announced this week. Amy Abernethy, FDA’s Principal Deputy Commissioner and Acting Chief Information Officer, joined the agency in 2019, and was named to head the CBD initiative that same year.
FDA CBD group leader departs
Like HempToday? How you can support us
Your donations help us to keep HempToday open for all readers, regardless of what they can afford to pay. Through this “information equality” we're able to support hemp entrepreneurs and stakeholders all over the world by keeping a spotlight on hemp and all the promise it offers for economic development and healing our planet.
